TGFB1 and neoplasm: TAMs, PMN‐MDSCs, and M‐MDSCs promote tumor development and metastasis by inhibiting T cells in a manner dependent on various cytokines and membrane‐associated molecules [3, 4, 5, 6]—including interleukin (IL)–10, transforming growth factor (TGF)–β, and CD40—that induce the differentiation of CD4 T cells into Tregs [7, 8].